Document:

EX-10.6

 Exhibit 10.6 

SUPPLEMENTAL AGREEMENT NO. 10 

to 
 Purchase Agreement
No. 3219 
 between 

THE BOEING COMPANY 
 and

 AMERICAN AIRLINES, INC. 

Relating to Boeing Model 787 Aircraft 

THIS SUPPLEMENTAL AGREEMENT No. 10 (SA-10) is made between THE BOEING COMPANY, a Delaware corporation with
offices in Seattle, Washington (Boeing), and AMERICAN AIRLINES, INC, a Delaware corporation with offices in Fort Worth, Texas, together with its successors and permitted assigns (Customer); 

WHEREAS, Boeing and Customer entered into Purchase Agreement No. 3219 dated October 15, 2008, relating to Boeing
Model 787 aircraft, as amended and supplemented (Purchase Agreement) and capitalized terms used herein without definitions shall have the meanings specified in such Purchase Agreement; and 

WHEREAS, Boeing and Customer desire to add Letter Agreement AAL-PA-03219-LA-1701988 entitled “[*CTR]”
(New 787 [*CTR] Letter Agreement); and 
 NOW, THEREFORE, the parties agree that the Purchase Agreement is amended
as set forth below and otherwise agree as follows: 
  

	1.	 Table of Contents. 

The Table of Contents referencing SA-9 in the footer is deleted in its entirety and is replaced with the new Table of Contents
(attached hereto) referencing SA-10 in the footer. Such new Table of Contents is hereby incorporated into the Purchase Agreement in replacement of its predecessor. 
  

	2.	 Tables. 

Table 1(R7).   Table 1(R6) entitled “787-9 Aircraft – Delivery, Description, Price and Advance
Payments” referencing SA-9 in the footer is deleted in its entirety and is replaced with 

  

					
	 PA 3219
	  	SA-10	  	Page 1        

 BOEING PROPRIETARY 

[*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

 
the similarly titled Table 1(R7) (attached hereto) referencing SA-10 in the footer. Table 1(R7) is hereby incorporated into the Purchase Agreement in replacement of Table 1(R6). 

 

	3.	 Letter Agreements. 

3.1        New [*CTR] Letter Agreement. The New 787 [*CTR] Letter Agreement is
added to the Purchase Agreement. The New 787 [*CTR] Letter Agreement is hereby made a part of the Purchase Agreement. 
  

	4.	 Effect on Purchase Agreement.  

4.1        Table 1 Reference Clarifications. The following references in the
Purchase Agreement and the associated exhibits, supplemental exhibits, and letter agreements to the Purchase Agreement to “Table 1(R6)” is now deemed to refer to “Table 1(R7)”. Specifically: 

 

	
	  

Location of References
  

	  

Articles 1, 2, 3 (all sections), 4 (all sections), and Section 5.1 of the Basic Articles

 

	  

Exhibit C(R1), Definitions of “Aircraft” and “Engine”

 

	  

Section 1 of Supplemental Exhibit AE1

 

	  

Section 1 of Supplemental Exhibit EE1

 

	  

Section 1 (definition of “Firm Aircraft”) of Letter Agreement 6-1162-TRW-0664R1 entitled
“Aircraft Purchase Rights and Substitution Rights”
  

	  

Section 1.1 of LA 6-1162-TRW-0672R1 entitled “[*CTR]”

 

	  

Section 3 of Letter Agreement 6-1162-TRW-0674R3 entitled “Business Considerations”

 4.2        Except as expressly set forth herein, all
terms and provisions contained in the Purchase Agreement shall remain in full force and effect. This Agreement contains the entire agreement between the parties with respect to the subject matter hereof and supersedes all previous proposals, and
agreements, understandings, commitments or representations whatsoever, oral or written, with respect to the subject matter hereof and may be changed only in writing signed by authorized representatives of the parties. 

  

					
	 PA 3219
	  	SA-10	  	Page 2        

 BOEING PROPRIETARY 

[*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

					
	  AGREED AND ACCEPTED	 		 	
			
	  May 11, 2017	 		 	
	  Date	 		 	
			
	  THE BOEING COMPANY	 		 	AMERICAN AIRLINES, INC.
			
	  /s/ The Boeing Company	 		 	/s/ American Airlines, Inc.
	  Signature	 		 	Signature
			
	  The Boeing Company	 		 	American Airlines, Inc.
	  Printed name	 		 	Printed name
			
	  Attorney-in-Fact	 		 	VP and Treasurer
	  Title	 		 	Title

  

					
	 PA 3219
	  	SA-10	  	Page 3        

 BOEING PROPRIETARY 

 TABLE OF CONTENTS 
  

					
	 ARTICLES
	    		  	 SA

NUMBER

	 1.
	    	Quantity, Model and Description	  	SA-3
	 2.
	    	Delivery Schedule	  	SA-3
	 3.
	    	Price	  	SA-3
	 4.
	    	Payment	  	SA-3
	 5.
	    	Miscellaneous	  	SA-3
	 6.
	    	Confidential Treatment	  	
			
	 TABLE
	    		  	
	 1.
	    	Aircraft Information Table – TRENT	  	SA-2
			
	 1(R7)
	    	 787-9 Aircraft Information Table – GENX
	  	SA-10
			
	 2(R1)
	    	 787-8 Aircraft Information Table – GENX

    ([*CTR] (12) 787-8 Aircraft)
	  	SA-5
			
	 3(R1)
	    	 787-8 Aircraft Information Table – GENX

    ([*CTR] Eight (8) 787-8 Aircraft, yielding Twenty (20) 787-8 Aircraft)
	  	SA-5
			
	 4
	    	WITHDRAWN	  	SA-6
			
	 EXHIBIT
	    		  	
	 A(R2).
	    	Aircraft Configuration for [*CTR] Aircraft	  	SA-7
	 A2(R3)
	    	Aircraft Configuration for [*CTR] Aircraft	  	SA-6
	 B(R1).
	    	Aircraft Delivery Requirements and Responsibilities	  	SA-3
	 C(R1).
	    	Defined Terms	  	SA-3

					
			
	 SUPPLEMENTAL EXHIBITS
	    		  	
	 AE1.
	    	[*CTR]	  	
			
	 BFE1(R1).
	    	Buyer Furnished Equipment Variables 787-9	  	SA-3
			
	 BFE2.
	    	Buyer Furnished Equipment Variables 787-8	  	SA-3
			
	 CS1.
	    	787 Customer Support Document	  	
			
	 EE1.
	    	[*CTR]	  	
			
	 EE1.
	    	[*CTR]	  	SA-2
			
	 EE2.
	    	[*CTR]	  	SA-4
			
	 SLP1.
	    	Service Life Policy Components	  	
			
	 LETTER AGREEMENTS
	    		  	SA
NUMBER
	 3219-01
	    	[*CTR]	  	
			
	 3219-02
	    	Special Terms – Seats and In-Flight Entertainment	  	

  

					
		  	P.A. No. 3219	  	SA-10
	 Table of Contents
	  		  	Page 1

 BOEING PROPRIETARY 

[*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

 TABLE OF CONTENTS, continued 

 

					
	 3219-04
	    	[*CTR]	  	
			
	 3219-05R1
	    	Spare Parts Commitments	  	SA-3
			
	 3219-06R1
	    	Spare Parts Initial Provisioning	  	SA-3
			
	 3219-08R2
	    	Open Configuration Matters Withdrawn	  	SA-8
			
	 6-1162-AKP-071R1
	    	[*CTR]
    Terminated per AAL-PA-1977-LA-1105595	  	
			
	 6-1162-AKP-072R2
	    	 [*CTR]
     Terminated
per AAL-PA-1977-LA-1105595
	  	
			
	 6-1162-AKP-073R1
	    	Accident Claims and Litigation	  	
			
	 6-1162-CLO-1031R1
	    	 [*CTR]
 WITHDRAWN
	  	 SA-2

SA-3

			
	 6-1162-CLO-1032R1
	    	 [*CTR]

    Terminated
	  	SA-3
			
	 6-1162-CLO-1039
	    	[*CTR]	  	
			
	 6-1162-CLO-1042
	    	[*CTR]	  	
			
	 6-1162-CLO-1043R1
	    	787 Inspection Process	  	SA-3
			
	 6-1162-CLO-1045R1
	    	[*CTR]	  	SA-2
			
	 6-1162-CLO-1046
	    	 SA-eE, COTS Software and End User License Matters

    WITHDRAWN
	  	SA-3
			
	 6-1162-CLO-1047R2
	    	[*CTR]	  	SA-6
			
	 6-1162-CLO-1048
	    	Final Matters	  	SA-2
			
	 6-1162-CLO-1049R2
	    	CS1 Matters	  	SA-6
			
	 6-1162-TRW-0664R1
	    	Aircraft Purchase Rights and Substitution Rights	  	SA-4
		    	Attachment A(R2) – MADP Exercise Dates	  	SA-6
		    	Attachment B(R2) – QADP Exercise Dates	  	SA-6
		    	 Attachment C(R3) – MADP & QADP Rights Aircraft:

    Description/Price Data
	  	SA-8
		    	Attachment D – Form of Purchase Agreement
    Supplement	  	SA-3
		    	Attachment E – Letter Agreements To Be Included In
    Purchase Agreement Supplement: WITHDRAWN	  	SA-6

  

					
		  	P.A. No. 3219	  	SA-10
	 Table of Contents
	  		  	Page 2

 BOEING PROPRIETARY 

[*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

 TABLE OF CONTENTS, continued 

 

					
	 LETTER AGREEMENTS
	    		  	SA
NUMBER
			
	 6-1162-TRW-0665
	    	[*CTR]	  	SA-3
			
	 6-1162-TRW-0666
	    	[*CTR]	  	SA-3
			
	 6-1162-TRW-0667R2
	    	[*CTR]	  	SA-6
			
	 6-1162-TRW-0668R1
	    	 Special Matters Relating to COTS Software and End

    User License Agreements
	  	SA-3
			
	 6-1162-TRW-0670R1
	    	Miscellaneous Commitments for Model 787 Aircraft	  	SA-3
			
	 6-1162-TRW-0671
	    	 [*CTR]

    WITHDRAWN
	  	SA-3
			
	 6-1162-TRW-0672R1
	    	Promotional Support Agreement	  	SA-3
			
	 6-1162-TRW-0673R1
	    	Confidentiality	  	SA-3
			
	 6-1162-TRW-0674R3
	    	Business Considerations	  	SA-6
			
	 AAL-PA-3219-LA-08836R1
	    	[*CTR]	  	SA-6
			
	 AAL-PA-3219-LA-08837R1
	    	[*CTR]	  	SA-6
			
	 AAL-PA-3219-LA-08838
	    	[*CTR]	  	SA-3
			
	 AAL-LA-1106678
	    	Assignment Matters	  	SA-3
			
	 AAL-PA-3219-LA-1302236R1
	    	[*CTR]	  	SA-6
			
	 AAL-PA-3219-LA-1604503
	    	787 [*CTR] Matters	  	SA-8
			
	 AAL-PA-03219-LA-1701988
	    	 [*CTR]
	  	 SA-10

  

					
		  	P.A. No. 3219	  	SA-10
	 Table of Contents
	  		  	Page 3

 BOEING PROPRIETARY 

[*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

 Table 1(R7) To Purchase Agreement No. PA-03219 

787-9 Aircraft Delivery, Description, Price and Advance Payments 

[*CTR] 
  

																	
	Airframe Model/MTOW:	 	787-9	 	553,000 pounds	 	        	 	Detail Specification:	 	[*CTR]	 		 		 	
								
	Engine Model/Thrust:	 	GENX-1B74/75	 	  74,100 pounds	 		 	Airframe Price Base Year/Escalation Formula:	 	[*CTR]	 		 	[*CTR]
								
	Airframe Price:	 		 	$[*CTR]	 		 	Engine Price Base Year/Escalation Formula:	 	[*CTR]	 		 	[*CTR]
									
	Optional Features:	 		 	    $[*CTR]	 		 		 		 		 		 	
									
	Sub-Total of Airframe and Features:	 		 	$[*CTR]	 		 	Airframe Escalation Data:	 		 		 		 	
									
	Engine Price (Per Aircraft):	 		 	$[*CTR]	 		 	Base Year Index (ECI):	 		 		 	[*CTR]	 	
								
	Aircraft Basic Price (Excluding BFE/SPE):	 	  $[*CTR]	 		 	Base Year Index (CPI):	 		 		 	[*CTR]	 	
									
		 		 	  
	 		 		 		 		 		 	
								
	Buyer Furnished Equipment (BFE) Estimate:	 	$[*CTR]	 		 	Engine Escalation Data:	 		 		 		 	
								
	In-Flight Entertainment (IFE) Estimate:	 	$[*CTR]	 		 	Base Year Index (ECI):	 		 		 	[*CTR]	 	
									
	Fixed Price Options	 		 	$[*CTR]	 		 	Base Year Index (CPI):	 		 		 	[*CTR]	 	
									
	Deposit per Aircraft:	 		 	$[*CTR]	 		 		 		 		 		 	

  

																			
	
Delivery
  

Date
	  	
Number of  
  

Aircraft  
	  	
Escalation  
  

Factor  
  

(Airframe)  
	  	
Escalation  
  

Factor  
  

(Engine)  
	  	
Manufacturer  
  

Serial Number  
	  	
Escalation Estimate  
  

Adv Payment Base  
  

Price Per A/P  
	  	Advance Payment Per Aircraft (Amts. 
Due/Mos. Prior to Delivery):
	  	  	  	  	  	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	
Total
  

        [*CTR]        

	
[*CTR]-2016  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2016  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2016  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2016  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2017  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2017  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2017  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2017  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2017  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2017  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2017  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2017  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2017  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]

  

					
	 AAL-PA-03219 105140-1F.txt
	  	 Boeing Proprietary
  
	  	 SA-10, Table 1(R7),

Page 1

 [*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED
SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

 Table 1(R7) To Purchase Agreement No. PA-03219 

787-9 Aircraft Delivery, Description, Price and Advance Payments 

[*CTR] 
  

																			
	
Delivery
  

Date
	  	
Number of  
  

Aircraft  
	  	  

Escalation  
  

Factor  
  

(Airframe)  
	  	
Escalation  
  

Factor  
  

(Engine)  
	  	
Manufacturer  
  

Serial Number  
	  	
Escalation Estimate  
  

Adv Payment Base  
  

Price Per A/P  
	  	Advance Payment Per Aircraft (Amts. 
Due/Mos. Prior to Delivery):
	  	  	  	  	  	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	
Total
  

        [*CTR]        

	
[*CTR]-2017  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2018  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2018  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2018  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2018  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2018  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2018  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2019  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]
	
[*CTR]-2019  
	  	1	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]	  	[*CTR]

       Total:
                    22 

  

					
	 AAL-PA-03219 105140-1F.txt
	  	 Boeing Proprietary
  
	  	 SA-10, Table 1(R7),

Page 2

 [*CTR]=[CONFIDENTIAL PORTION
OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

							
	 

	 	 	  	 The Boeing Company

P.O. Box 3707
 Seattle, WA 98124-2207
  

 AAL-PA-3219-LA-1701988 

American Airlines, Inc. 
 P.O. Box 619616 

Dallas-Fort Worth Airport, Texas 75261-9616 
  

	Subject:	 [*CTR] 

  

	Reference:	 Purchase Agreement No. PA-3219 (Purchase Agreement) between The Boeing Company (Boeing) and American
Airlines, Inc. (Customer) relating to Model 787 aircraft (Aircraft) 

 This letter
agreement (Letter Agreement) is entered into on the date below and amends and supplements the Purchase Agreement referenced above. All capitalized terms used in but not otherwise defined in this Letter Agreement shall have the same meaning as
in the Purchase Agreement. 
 Customer and Boeing previously entered into the [*CTR] Letter Agreement which [*CTR] described in
Attachment A to the [*CTR] Letter Agreement (collectively referred to as [*CTR] or [*CTR]). Customer has requested and Boeing agrees to the [*CTR]. 

In order to accomplish this [*CTR], Customer and Boeing agree that [*CTR] (as defined below) will be utilized for the [*CTR] identified
in Attachment A hereto that will be [*CTR]. 
 In order to document the use of the [*CTR], the parties agree as follows: 

1.         Revisions to the [*CTR] Letter Agreement. [*CTR], the [*CTR] Letter Agreement is revised
as follows: 
  

	 	1.1	 Section 1.1.5 is deleted in its entirety and replaced with the following: 

“1.1.5 [*CTR], but such [*CTR]: 
  

	 	1.1.5.1	 specify that [*CTR]; 

  

	 	1.1.5.2	 specify the [*CTR]; 

  

	 	1.1.5.3	 require [*CTR]; and 

  

	 	1.1.5.4	 require [*CTR];” 

  

	 	1.2	 Section 1.1.6 is deleted in its entirety and replaced with the following: 

  

					
	 AAL-PA-3219-LA-1701988

[*CTR],
 Letter Agreement
AAL-PA-3219-LA-1302236R1
	  	 SA-9
  

LA Page 1

 BOEING PROPRIETARY

 [*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

							
	 

	 		  	

  
 “1.1.6 Intentionally
Omitted” 
 1.3       Section 1.2.4 is deleted in its entirety and replaced with the
following: 
 “1.2.4 place, [*CTR] and which shall also include a statement that [*CTR]; additionally the
[*CTR];” 
 1.4       Sections 1.2.5 through 1.2.8 are renumbered so that Section 1.2.5
becomes 1.2.7, Section 1.2.6 becomes Section 1.2.8, Section 1.2.7 becomes Section 1.2.9, and Section 1.2.8 becomes Section 1.2.10. 

1.5       After Section 1.2.4, the following new sections are added: 

“1.2.5 notify Customer as soon as possible [*CTR]; 

1.2.6 manage all [*CTR],” 

1.6       Section 4.1.1 is amended by replacing the words “the [*CTR]” with “the
[*CTR].” 
 1.7       Section 6.1 is amended by replacing the words “[*CTR]”
with “[*CTR].” 
 1.8       Section 8.1 is deleted in its entirety and replaced with
the following: 
 “8.1      [*CTR]. An [*CTR] for each Aircraft. Boeing and
Customer agree that the [*CTR] for such Aircraft.” 
 1.9       Section 8.2 is deleted in
its entirety and replaced with the following: 
 “8.2      Aircraft [*CTR].
The Aircraft [*CTR] for the [*CTR]..” 
 1.10     Section 10 is deleted in its entirety and replaced
with the following: 
 “10.      [*CTR]. [*CTR] will at all times [*CTR] with
Customer [*CTR] and Boeing will have [*CTR] would have, but will not be [*CTR].” 

  

					
	 AAL-PA-3219-LA-1701988

[*CTR],
 Letter Agreement
AAL-PA-3219-LA-1302236R1
	  	 SA-9
  

LA Page 2

 BOEING PROPRIETARY

 [*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

							
	 

	 		  	

  
  

	2.	 Confidential Treatment. 

Customer and Boeing understand and agree that the information contained herein represents confidential business information and has
value precisely because it is not generally available to other parties. This Letter Agreement shall be subject to the terms and conditions of Letter Agreement 6-1162-TRW-0673R1 entitled
“Confidentiality”. 
 If the foregoing correctly sets forth your understanding of our agreement with respect to the
matters treated above, please indicate your acceptance and approval below. 

  

					
	 AAL-PA-3219-LA-1701988

[*CTR],
 Letter Agreement
AAL-PA-3219-LA-1302236R1
	  	 SA-9
  

LA Page 3

 BOEING PROPRIETARY

 [*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

							
	 

	 		  	

  
  

Very truly yours, 
  

			
	 THE BOEING COMPANY

		
	 By
	 	   /s/ The Boeing Company

		 	  

		
	 Its
	 	   Attorney-In-Fact

		 	  

	
	 ACCEPTED AND AGREED TO this

		
	 Date:
	 	   May 11, 2017

		 	  

	
	 AMERICAN AIRLINES, INC.

		
	 By
	 	   /s/ American Airlines, Inc.

		 	  

		
	 Its
	 	   VP and Treasurer

		 	  

 Attachments 

  

					
	 AAL-PA-3219-LA-1701988

[*CTR],
 Letter Agreement
AAL-PA-3219-LA-1302236R1
	  	 SA-9
  

LA Page 4

 BOEING PROPRIETARY

 [*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

							
	 

	 		  	

 

 Attachment A 

[*CTR] 
  

									
	[*CTR]	  	[*CTR]	  	  

[*CTR]
  
	  	[*CTR]	  	[*CTR]
	 
	[*CTR]
	                [*CTR]  	  	                1  
	  	 [*CTR]

 
	  	[*CTR]  	  	            [*CTR]  

	[*CTR]  	  	2  	  	 [*CTR]
	  	[*CTR]  	  	[*CTR]  
	 	  	3  	  	 [*CTR]

 
	  	[*CTR]  	  	[*CTR]  
	 	  	4  	  	 [*CTR]

 
	  	[*CTR]  	  	[*CTR]  
	 	  	5  	  	 [*CTR]
	  	[*CTR]  	  	[*CTR]  
	 	  	6  	  	 [*CTR]
	  	[*CTR]  	  	[*CTR]  
	 	  	7  	  	 [*CTR]
	  	[*CTR]  	  	[*CTR]  
	 	  	8  	  	 [*CTR]

 
  
  
	  	[*CTR]  	  	[*CTR]  
	 	  	9  	  	 [*CTR]

 
  
	  	[*CTR]  	  	[*CTR]  
	 	  	10  	  	 [*CTR]
	  	[*CTR]  	  	[*CTR]  
	 	  	11  	  	 [*CTR]
	  	[*CTR]  	  	[*CTR]  

 

 

 
  
  
 

 
  
  
 

 

 

  

					
	 Attachment A to AAL-PA-3219-LA-1701988

[*CTR],
 Letter Agreement
AAL-PA-3219-LA-1302236R1
	  	

 BOEING PROPRIETARY 

[*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

							
	 

	 		  	

 

  

									
	[*CTR]	  	[*CTR]  	  	  

[*CTR]
  
	  	[*CTR]	  	[*CTR]
	 
	[*CTR]
	
            [*CTR]  
	  	1  	  	 [*CTR]  

 
	  	[*CTR]  	  	[*CTR]  
	[*CTR]  	  	2  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	3  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	4  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	5  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	6  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	7  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	8  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	9  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	10  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	11  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	12  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	13  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	14  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	15  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	16  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	[*CTR]  	  	1  	  	 [*CTR]  

 
	  	[*CTR]  	  	[*CTR]  
	[*CTR]  	  	2  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	3  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	4  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	5  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	6  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	7  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	8  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	9  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	10  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	11  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	12  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	13  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	14  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  

 

 

 
  
  
 

 
  
  
 

 

 

  

					
	 Attachment A to AAL-PA-3219-LA-1701988

[*CTR],
 Letter Agreement
AAL-PA-3219-LA-1302236R1
	  	

 BOEING PROPRIETARY 

[*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

							
	 

	 		  	

  
  

									
	 	  	            15  	  	[*CTR]  	  	[*CTR]  	  	            [*CTR]  
	 	  	16  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	17  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	            [*CTR]  	  	1  	  	 [*CTR]  

 
	  	[*CTR]  	  	[*CTR]  
	[*CTR]  	  	2  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	3  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	4  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	5  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	6  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	7  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	8  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	9  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	10  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	11  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	12  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	13  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	14  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	15  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	16  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	17  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	18  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  

  

					
	 Attachment A to AAL-PA-3219-LA-1701988

[*CTR],
 Letter Agreement
AAL-PA-3219-LA-1302236R1
	  	

 BOEING PROPRIETARY 

[*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

							
	 

	 		  	

  
  

									
	[*CTR]	  	[*CTR]  	  	  

[*CTR]
  
	  	[*CTR]	  	[*CTR]
	 
	[*CTR]
	
                [*CTR]  
	  	1  	  	 [*CTR]

 
	  	[*CTR]  	  	            [*CTR]  

	
                [*CTR]  
	  	2  	  	[*CTR]	  	[*CTR]  	  	[*CTR]  
	 	  	3  	  	 [*CTR]

 
	  	[*CTR]  	  	[*CTR]  
	 	  	4  	  	 [*CTR]

 
	  	[*CTR]  	  	[*CTR]  
	 	  	5  	  	[*CTR]	  	[*CTR]  	  	[*CTR]  
	 	  	6  	  	[*CTR]	  	[*CTR]  	  	[*CTR]  
	 	  	7  	  	[*CTR]	  	[*CTR]  	  	[*CTR]  
	 	  	8  	  	 [*CTR]

 
	  	[*CTR]  	  	[*CTR]  
	 	  	9  	  	 [*CTR]

 
	  	[*CTR]  	  	[*CTR]  
	 	  	10  	  	[*CTR]	  	[*CTR]  	  	[*CTR]  
	 	  	11  	  	[*CTR]	  	[*CTR]  	  	[*CTR]  

  

					
	 Attachment A to AAL-PA-3219-LA-1701988

[*CTR],
 Letter Agreement
AAL-PA-3219-LA-1302236R1
	  	

 BOEING PROPRIETARY 

[*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

							
	 

	 		  	

  
  

									
	[*CTR]	  	[*CTR]  	  	  

[*CTR]
  
	  	[*CTR]	  	[*CTR]
	 
	[*CTR]
	
            [*CTR]  
	  	1	  	 [*CTR]  

 
	  	[*CTR]  	  	          [*CTR]  
	[*CTR]]  	  	2	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	3	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	4	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	5	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	6	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	7	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	8	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	9	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	10	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	11	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	12	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	13	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	14	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	15	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	16	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	17	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	18	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	[*CTR]  	  	1	  	 [*CTR]  

 
	  	[*CTR]  	  	[*CTR]  
	[*CTR]  	  	2	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	3	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	4	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	5	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	6	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	7	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	8	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	9	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	10	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	11	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	12	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  

  

					
	 Attachment A to AAL-PA-3219-LA-1701988

[*CTR],
 Letter Agreement
AAL-PA-3219-LA-1302236R1
	  	

 BOEING PROPRIETARY 

[*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

							
	 

	 		  	

  
  

									
	 	  	13  	  	[*CTR]  	  	[*CTR]  	  	            [*CTR]  
	 	  	            14  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	15  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	16  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	17  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	18  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	            [*CTR]  	  	1  	  	 [*CTR]  

 
	  	[*CTR]  	  	[*CTR]  
	[*CTR]  	  	2  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	3  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	4  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	5  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	6  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	7  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	8  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	9  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	10  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	11  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	12  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	13  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	14  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	15  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	16  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  
	 	  	17  	  	[*CTR]  	  	[*CTR]  	  	[*CTR]  

  

					
	 Attachment A to AAL-PA-3219-LA-1701988

[*CTR],
 Letter Agreement
AAL-PA-3219-LA-1302236R1
	  	

 BOEING PROPRIETARY 

[*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]ex10-1.htm

Exhibit 10.1

 

AMENDMENT

TO

MARKETING AUTHORIZATION HOLDER AGREEMENT

(“Amendment 3”)

 

This Amendment (“Amendment 3”) is made this July 7th, 2017, by and between Oxford Immunotec Limited, a company organized and existing under the laws of UK, address at 94C Innovation Drive Milton Park, Abingdon, Oxfordshire OX14 4RZ United Kingdom (hereinafter referred to as "MANUFACTURER", and RIKEN GENESIS CO., LTD., a company organized and existing under the laws of Japan, address at Art Village Osaki Central Tower 8F, 1-2-2 Osaki, Shinagawa-ku, Tokyo 141-0032, Japan (hereinafter referred to as “MAH”).

 

Recitals:

WHEREAS, MANUFACTURER and MAH are parties to the Marketing Authorization Holder Agreement dated July 29, 2011, as amended on September 1, 2013 and on April 1, 2016 (“Agreement”); and

WHEREAS, as of July 7th, 2017 (“Effective Date”), the parties agreed to modify the Agreement to alter the provision regarding the duration thereof and correct a part of AMENDMENT TO MARKETING AUTHORIZATION HOLDER AGREEMENT dated April 1, 2016 (“Amendment 2”).

NOW, THEREFORE, IN CONSIDERATION OF THE FOREGOING, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged and agreed, MANUFACTURER and MAH agree to amend the Agreement as follows:

 

	
			1.

				
			This Amendment 3 shall have effect as of the Effective Date. Notwithstanding the foregoing, the amendment under Section3. hereof shall be effective retroactively from April 1, 2016.

			

	
			2.

				
			Section 9.1 of the Agreement shall be eliminated and replaced with as follows:

			This Agreement takes effect on the Effective Date set forth above and will automatically renew on each one (1) year-anniversary unless written notice is given by either party not less than six (6) months prior to the such anniversary. In the event such notice is given, the Agreement will expire on the next anniversary of the Effective Date (“Next Anniversary”). Notwithstanding the foregoing sentence, MANUFACTURER may, at its sole discretion, give notice to MAH at any time during such six-month period of time, and in such a case, the Agreement shall expire on the day, which is earlier than the Next Anniversary, specified in the said notice given by MANUFACTURER unless MAH opposes to such earlier expiration.

			

	
			3.

				
			The first sentence in the second paragraph of “Fee Structure” in APPENDIX A of the Amendment 2, starting with “We” and ending with “DISTRIBUTOR” shall be amended to read as follows:

			We charge a monthly retainer handling fee and commission per commercial invoice at custom clearance for PRODUCTS listed in APPENDIX B on the proviso that PRODUCTS are directly delivered from MANUFACTURER to DISTRIBUTOR.

			

	
			4.

				
			Except for the terms and conductions set forth above, all terms and conditions of the Agreement shall remain in full force and effect.

			

 

 

 

  

IN WITNESS WHEREOF, the parties have executed this Amendment 3 as of the date first above written.

 

	
			RIKEN GENESIS CO., LTD. 

				 	
			Oxford Immunotec Limited

				 
	
			By:

				
			 

			 

			 

			/s/ Noto Kondo

				 	
			By:

				
			/s/ Peter Wrighton-Smith

			
	 	 	 	 	 
	
			Name:

				
			Noto Kondo

				 	
			Name:

				
			Peter Wrighton-Smith

			
	 	 	 	 	 
	
			Title:

				
			CEO

				 	
			Title:

				
			CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00273-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00273-of-00352.parquet"}]]